156 related articles for article (PubMed ID: 37516837)
1. Randomized, double-blinded, placebo-controlled pilot study: efficacy of faecal microbiota transplantation on chronic fatigue syndrome.
Salonen T; Jokinen E; Satokari R; Lahtinen P
J Transl Med; 2023 Jul; 21(1):513. PubMed ID: 37516837
[TBL] [Abstract][Full Text] [Related]
2. Faecal microbiota transplantation (FMT) in Norwegian outpatients with mild to severe myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): protocol for a 12-month randomised double-blind placebo-controlled trial.
Skjevling L; Goll R; Hanssen HM; Johnsen PH
BMJ Open; 2024 Jun; 14(6):e073275. PubMed ID: 38858151
[TBL] [Abstract][Full Text] [Related]
3. Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study.
Halkjær SI; Christensen AH; Lo BZS; Browne PD; Günther S; Hansen LH; Petersen AM
Gut; 2018 Dec; 67(12):2107-2115. PubMed ID: 29980607
[TBL] [Abstract][Full Text] [Related]
4. Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome With Predominant Abdominal Bloating: Short- and Long-term Results From a Placebo-Controlled Randomized Trial.
Holvoet T; Joossens M; Vázquez-Castellanos JF; Christiaens E; Heyerick L; Boelens J; Verhasselt B; van Vlierberghe H; De Vos M; Raes J; De Looze D
Gastroenterology; 2021 Jan; 160(1):145-157.e8. PubMed ID: 32681922
[TBL] [Abstract][Full Text] [Related]
5. The effect of fecal microbiota transplantation on IBS related quality of life and fatigue in moderate to severe non-constipated irritable bowel: Secondary endpoints of a double blind, randomized, placebo-controlled trial.
Johnsen PH; Hilpüsch F; Valle PC; Goll R
EBioMedicine; 2020 Jan; 51():102562. PubMed ID: 31877418
[TBL] [Abstract][Full Text] [Related]
6. Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial.
Aroniadis OC; Brandt LJ; Oneto C; Feuerstadt P; Sherman A; Wolkoff AW; Kassam Z; Sadovsky RG; Elliott RJ; Budree S; Kim M; Keller MJ
Lancet Gastroenterol Hepatol; 2019 Sep; 4(9):675-685. PubMed ID: 31326345
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study.
El-Salhy M; Hatlebakk JG; Gilja OH; Bråthen Kristoffersen A; Hausken T
Gut; 2020 May; 69(5):859-867. PubMed ID: 31852769
[TBL] [Abstract][Full Text] [Related]
8. Sijunzi decoction, a classical Chinese herbal formula, improves fatigue symptoms with changes in gut microbiota in chronic fatigue syndrome: A randomized, double-blind, placebo-controlled, multi-center clinical trial.
Dai L; Liu Z; Zhou W; Zhang L; Miao M; Wang L; Hua H; Wang B; Ji G
Phytomedicine; 2024 Jul; 129():155636. PubMed ID: 38640860
[TBL] [Abstract][Full Text] [Related]
9. Fecal microbiota transplantation for the improvement of metabolism in obesity: The FMT-TRIM double-blind placebo-controlled pilot trial.
Yu EW; Gao L; Stastka P; Cheney MC; Mahabamunuge J; Torres Soto M; Ford CB; Bryant JA; Henn MR; Hohmann EL
PLoS Med; 2020 Mar; 17(3):e1003051. PubMed ID: 32150549
[TBL] [Abstract][Full Text] [Related]
10. Randomised clinical trial: faecal microbiota transplantation versus autologous placebo administered via colonoscopy in irritable bowel syndrome.
Lahtinen P; Jalanka J; Hartikainen A; Mattila E; Hillilä M; Punkkinen J; Koskenpato J; Anttila VJ; Tillonen J; Satokari R; Arkkila P
Aliment Pharmacol Ther; 2020 Jun; 51(12):1321-1331. PubMed ID: 32343000
[TBL] [Abstract][Full Text] [Related]
11. Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial.
Johnsen PH; Hilpüsch F; Cavanagh JP; Leikanger IS; Kolstad C; Valle PC; Goll R
Lancet Gastroenterol Hepatol; 2018 Jan; 3(1):17-24. PubMed ID: 29100842
[TBL] [Abstract][Full Text] [Related]
12. Feasibility, Acceptability, and Safety of Faecal Microbiota Transplantation in the Treatment of Major Depressive Disorder: A Pilot Randomized Controlled Trial.
Green JE; Berk M; Mohebbi M; Loughman A; McGuinness AJ; Castle D; Chatterton ML; Perez J; Strandwitz P; Athan E; Hair C; Nierenberg AA; Cryan JF; Jacka F
Can J Psychiatry; 2023 May; 68(5):315-326. PubMed ID: 36637229
[TBL] [Abstract][Full Text] [Related]
13. Responses to faecal microbiota transplantation in female and male patients with irritable bowel syndrome.
El-Salhy M; Casen C; Valeur J; Hausken T; Hatlebakk JG
World J Gastroenterol; 2021 May; 27(18):2219-2237. PubMed ID: 34025075
[TBL] [Abstract][Full Text] [Related]
14. Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial.
Haifer C; Paramsothy S; Kaakoush NO; Saikal A; Ghaly S; Yang T; Luu LDW; Borody TJ; Leong RW
Lancet Gastroenterol Hepatol; 2022 Feb; 7(2):141-151. PubMed ID: 34863330
[TBL] [Abstract][Full Text] [Related]
15. Effects of Fecal Microbiota Transplantation With Oral Capsules in Obese Patients.
Allegretti JR; Kassam Z; Mullish BH; Chiang A; Carrellas M; Hurtado J; Marchesi JR; McDonald JAK; Pechlivanis A; Barker GF; Miguéns Blanco J; Garcia-Perez I; Wong WF; Gerardin Y; Silverstein M; Kennedy K; Thompson C
Clin Gastroenterol Hepatol; 2020 Apr; 18(4):855-863.e2. PubMed ID: 31301451
[TBL] [Abstract][Full Text] [Related]
16. Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection: A Randomized Trial.
Kelly CR; Khoruts A; Staley C; Sadowsky MJ; Abd M; Alani M; Bakow B; Curran P; McKenney J; Tisch A; Reinert SE; Machan JT; Brandt LJ
Ann Intern Med; 2016 Nov; 165(9):609-616. PubMed ID: 27547925
[TBL] [Abstract][Full Text] [Related]
17. The fecal microbiota transplantation response differs between patients with severe and moderate irritable bowel symptoms.
El-Salhy M; Mazzawi T; Hausken T; Hatlebakk JG
Scand J Gastroenterol; 2022 Sep; 57(9):1036-1045. PubMed ID: 35486073
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Fecal Microbiota Transplantation for Patients With Irritable Bowel Syndrome at 3 Years After Transplantation.
El-Salhy M; Winkel R; Casen C; Hausken T; Gilja OH; Hatlebakk JG
Gastroenterology; 2022 Oct; 163(4):982-994.e14. PubMed ID: 35709830
[TBL] [Abstract][Full Text] [Related]
19. Safety and feasibility of faecal microbiota transplantation for patients with Parkinson's disease: a protocol for a self-controlled interventional donor-FMT pilot study.
Vendrik KE; Chernova VO; Kuijper EJ; Terveer EM; van Hilten JJ; Contarino MF;
BMJ Open; 2023 Oct; 13(10):e071766. PubMed ID: 37798034
[TBL] [Abstract][Full Text] [Related]
20. Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis: A Randomized Clinical Trial.
Costello SP; Hughes PA; Waters O; Bryant RV; Vincent AD; Blatchford P; Katsikeros R; Makanyanga J; Campaniello MA; Mavrangelos C; Rosewarne CP; Bickley C; Peters C; Schoeman MN; Conlon MA; Roberts-Thomson IC; Andrews JM
JAMA; 2019 Jan; 321(2):156-164. PubMed ID: 30644982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
